SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending due to the announcement of a technological breakthrough that enables multiple data centers to operate as a single logical supercluster with high-speed, low-latency connectivity. The community is actively discussing this infrastructure innovation alongside rising institutional interest, while some traders continue to highlight the stock's significant short interest and volatile price action as potential catalysts for further movement.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened volatility as investors grapple with multi-year lows and ongoing dilution concerns, with the community actively debating whether the stock represents a deep-value opportunity or a failed turnaround. While some participants are aggressively accumulating shares to force a short squeeze, others express intense frustration toward management's capital allocation and lack of clear strategic communication.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing significant downward pressure following a guidance cut and the unexpected departure of its CFO and CMO, leading to an intense debate among investors over whether this is a structural failure or a temporary overreaction to a solid earnings beat. The community remains deeply divided, with bulls pointing to the company's growth in the U.S. and strategic partnerships as long-term catalysts, while bears are emphasizing the deteriorating outlook and leadership uncertainty.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is rallying following strong positive Phase 3 trial results for its drug candidate avexitide, which met all primary and secondary endpoints. The community is actively debating the stock's significant move, with many focusing on the potential for a buyout, strong institutional backing, and the company's improved cash position despite active speculation regarding future share dilution.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind its legal and licensing momentum, particularly following a significant settlement with Samsung and a newly initiated ITC action against Micron. The community remains highly focused on upcoming catalysts like the September 9th Federal Circuit hearing and potential further licensing deals, with many investors viewing volatility as a chance to accumulate shares amidst a conviction-led long-term outlook.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is capturing market attention as it nears its Q2 earnings report, with the community actively debating whether the companys recent store-level turnaround and foot traffic gains justify its significant year-to-date rally. While some investors are betting on a positive surprise that could push shares higher, others are wary that high expectations are already priced in, setting the stage for potential volatility following the release.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold is rallying as soft jobs data and cooling inflation expectations dampen the likelihood of near-term interest rate hikes, shifting capital toward the metal as a safe-haven asset. The community is actively debating whether this momentum marks the start of a sustained bull run or if the move is a temporary reprieve, with many closely watching bond yields and geopolitical tensions as key drivers for further gains.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.

Heartflow Inc

Heartflow, Inc.

Heartflow is experiencing significant volatility as community members debate whether the stock is a high-growth AI healthcare play or a heavily manipulated pump trading at unsustainable valuations. While some investors focus on recent earnings beats and institutional positioning, a vocal segment of the community warns of aggressive insider selling and future share dilution that could trigger a sharp correction.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently trending as investors weigh significant institutional interest and robust power infrastructure contracts against broader market volatility and persistent selling pressure in the data center sector. The community is actively debating whether the stock's current price represents a buying opportunity or a deeper correction, with many retail investors focused on potential short-squeeze dynamics and the long-term impact of its hyperscaler partnerships.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is experiencing significant volatility as investors weigh the company's ambitious expansion into humanoid robotics, robotaxis, and international markets against ongoing concerns regarding macroeconomic pressures on Chinese stocks. While community sentiment remains polarized between long-term bulls highlighting strong delivery growth and technological advancements and bears skeptical of profitability, many are focused on whether current price levels offer a historical entry point ahead of upcoming delivery data and product rollouts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Candel Therapeutics is trending as investors focus on the company's clear clinical progress and upcoming milestones, specifically the planned BLA submission for its prostate cancer therapy and active Phase 3 trials in lung cancer. The community is actively discussing the stock's significant institutional backing, robust cash runway, and the potential for a strategic partnership or acquisition as the company transitions toward commercialization.

CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4

Equity

If the FDA approves aglatimagene besadenovec in the treatment of certain patients with prostate cancer, it would mark the company’s first commercial product. 


CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug —  Eyes $10–$16B Opportunity 

Shares of Candel have drawn rising attention as the company advances its experimental immunotherapy, known as CAN-2409 or aglatimagene, toward potential approval in localized prostate cancer.


CADL Stock Heads For Biggest Monthly Gains Since December 2024 – Retail Says ‘Our SLS Days Are Coming’

Candel Therapeutics announced the initiation of a Phase 3 trial evaluating lead therapy CAN-2409 in advanced non-small cell lung cancer patients.

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

Candel Therapeutics Phase 3 prostate cancer trial showed a higher disease-free survival rate.

Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade

The mean of analysts' price targets for Candel Therapeutics (CADL) points to a 148.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data

Candel Therapeutics presented positive phase 3 prostate cancer data showing improved disease-free survival, while analysts maintained bullish expectations on the stock.read more...

CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data  

The company reported that, after a median follow-up of 58 months, CAN-2409 delivered a statistically significant 39% improvement in prostate cancer-specific disease-free survival versus placebo. 

CADL Retail Bulls See Buyout Potential As Key Cancer Data Catalyst Approaches

Candel Therapeutics is set to present data on Friday from its Phase 3 clinical trial of Aglatimagene in patients with localized, intermediate- to high-risk prostate cancer

Candel Therapeutics Reported Better-Than-Feared Q1 Loss – But All Eyes Turn To This Pivotal Event Tomorrow 

Candel Therapeutics generated investor buzz ahead of a key prostate cancer data readout, while its first-quarter loss came narrower than consensus estimates.

Candel Therapeutics (NASDAQ:CADL) Sets New 12-Month High  - Here's What Happened

Candel Therapeutics (NASDAQ:CADL) Hits New 52-Week High - What's Next...

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are actively debating high-value acquisition scenarios, with many forecasting potential 15 billion dollar interest from industry giants like J&J.

Smart money interest is surging as major firms like Goldman Sachs and Wellington aggressively expand their positions, signalizing long-term confidence.

Anticipation is building for the late September ASTRO meeting and the Q4 BLA submission, which traders view as critical value-unlocking milestones.

Aggressive retail chatter highlights a battle against short sellers, aiming to trap positions as the stock price climbs and volume patterns stabilize.

Supporters believe the extremely limited public float, combined with high institutional stakes, is creating an explosive environment for potential upside momentum.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.33	--	--	N/A
Q2 '26	-$0.23	-$0.52	-127.21%	MISSED
Q1 '26	-$0.30	-$0.14	52.68%	BEAT
Q4 '25	-$0.24	-$0.54	-120.94%	MISSED
Q3 '25	-$0.19	-$0.21	-13.40%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings